- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Beta Drugs revised its valuation report for the Nivian Life Sciences acquisition. The preferential issue valuation now uses consolidated financials, shifting from standalone for a more complete picture.